서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 5 of 5

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2023-05	Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancer Slamon, Dennis J.; Fasching, Peter A.; Hurvitz, Sara; Chia, Stephen; Crown, John; Martin, Miguel; Barrios, Carlos H.; Bardia, Aditya; Im, Seock-Ah; Yardley, Denise A.; Untch, Michael; Huang, Chiun-Sheng; Stroyakovskiy, Daniil; Xu, Binghe; Moroose, Rebecca L.; Loi, Sherene; Visco, Frances; Bee-Munteanu, Valerie; Afenjar, Karen; Fresco, Rodrigo; Taran, Tetiana; Chakravartty, Arunava; Zarate, Juan Pablo; Lteif, Agnes; Hortobagyi, Gabriel N. Therapeutic Advances in Medical Oncology, Vol.15, pp.1-16	DOI
2023-06	Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results. Meric-Bernstam, Funda; Makker, Vicky; Oaknin, Ana; Oh, Do Youn; Banerjee, Susana N.; Martin, Antonio Gonzalez; Jung, Kyung Hae; Lugowska, Iwona A.; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Anoka, Chiedozie; Ma, Yan; Puvvada, Soham D.; Lee, Jung-Yun Journal of Clinical Oncology, Vol.41 No.17_SUPPL, pp.LBA3000-LBA3000	DOI
2024-01	Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial Meric-Bernstam, Funda; Makker, Vicky; Oaknin, Ana; Oh, Do-Youn; Banerjee, Susana; González-Martín, Antonio; Jung, Kyung Hae; Ługowska, Iwona; Manso, Luis; Manzano, Aránzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Ma, Yan; Puvvada, Soham; Shire, Norah; Lee, Jung-Yun Journal of Clinical Oncology, Vol.42 No.1, pp.47-58	DOI
2024-03	Ribociclib plus Endocrine Therapy in Early Breast Cancer Slamon, Dennis; Lipatov, Oleg; Nowecki, Zbigniew; McAndrew, Nicholas; Kukielka-Budny, Bozena; Stroyakovskiy, Daniil; Yardley, Denise A.; Huang, Chiun-Sheng; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Ruiz-Borrego, Manuel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Afenjar, Karen; Fresco, Rodrigo; Severin, Irene; Ji, Yan; Ghaznawi, Farhat; Li, Zheng; Zarate, Juan P.; Chakravartty, Arunava; Taran, Tetiana; Hortobagyi, Gabriel New England Journal of Medicine, Vol.390 No.12, pp.1080-1091	DOI
2024-11	Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 Oaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda ADVANCES IN THERAPY, Vol.41 No.11, pp.4125-4139	DOI

1